Scientist hypothesize that Sativex, a cannabinoid-containing mouth spray that tastes like mint, may be helpful in the reduction of symptoms such as aggression, agitation and paranoia. Researchers at King’s College London have announced that cannabis will be used as an experimental treatment for the symptoms of dementia, in what will be the first major UK clinical trial to treat the disease with the drug. 60 volunteer patients that display symptoms of dementia and Alzhemier’s are to be recruited, with results of cannabis treatment compared to those of a placebo. Most patients will be elderly people who live in nursing or assisted living homes, and all will be between 55 and 90 years old. Scientist hypothesize that Sativex, a cannabinoid-containing mouth spray that tastes like mint, may be helpful in the reduction of symptoms such as aggression, agitation and paranoia. Nearly half of all dementia patients in the UK suffer from these symptoms, in addition to confusion, lapses of me...
Komentarze
Prześlij komentarz